has completed a strategic alliance agreement with the Technological University of Queretaro (UTEQ), for the provision of Tekcapital’s services in Mexico.
The new alliance was announced at UTEQ’s Industry 4.0 event celebrating their 25th anniversary, where central issues included innovation challenges and opportunities. Tekcapital was invited to speak at numerous events to aid their acceleration of “university technology commercialization, start-up company formation and cluster development.”
Dr. Clifford Gross, Executive Chairman of Tekcapital, commented on the alliance, “We are enthusiastic about moving forward with this strategic alliance as UTEQ is a university innovation thought leader and Mexico is a rapidly growing market for Tekcapital's technology investment and commercialisation services."
The UK intellectual property investment group believes this particular partnership will flourish, in part, thanks to UTEQ’s prime location in the “high-tech zone” of Queretaro, cultivating the region’s technology and innovation scene.
UTEQ has become a firm supporter of this push, creating the Creativity and Innovation Center (CIC) 4.0 as a way to “promote industry commercialization of university technology.”
And this is where the alliance seems bound to mutually benefit the partners— Tekcapital places a strong focus on cultivating IP from university technologies.
Provost of UTEQ Jose Carlos Arrendondo also spoke on the strategic alliance, commenting, “For our ecosystem, Tekcapital represents a strategic link that will strengthen the culture of valuing the intellectual property arising from innovation, applied research and the technological development of the academia in Mexico."
For more news and updates on Tekcapital:
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
“We are extremely pleased to address another market with our first oncology test which has already seen traction in the UK and Europe since its launch in September 2019, and reinforces our strategic plans of product penetration and geographic expansion,” said Lyn Rees, Chief Executive of Yourgene.
Boris Johnson's new cabinet will meet for the first time later, following a reshuffle that saw Sajid Javid quit his role as chancellor. The prime minister had offered to reappoint Mr Javid on the condition he fire his team of aides a demand rejected by Mr Javid which means Rishi Sunak, former chief secretary to the Treasury, has been appointed as the new Chancellor.